1. Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma 
Marcel P. Devetten, Parameswaran N. Hari, Jeanette Carreras, Brent R. Logan, Koen van Besien, Christopher N. Bredeson, César O. Freytes, Robert Peter Gale, John Gibson, Sergio A. Giralt, Steven C. Goldstein, Vikas Gupta, David I. Marks, Richard T. Maziarz, Julie M. Vose, Hillard M. Lazarus, Paolo Anderlini 
Biology of Blood and Marrow Transplantation 
Volume 15, Issue 1, Pages (January 2009)
DOI: /j.bbmt
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
TRM, relapse/progression (a), PFS, and OS (b), aGVHD (c), and cGVHD (d) after unrelated donor RIC/NST HCT for relapsed/refractory HL.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Effect of chemosensitivity at the time of transplantation on PFS (a) and OS (b) after unrelated donor RIC/NST HCT for relapsed/refractory HL.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions